All.Can is committed to efficiency in cancer care. By working with all stakeholders, we aim to achieve our goal: better health outcomes for cancer patients. This is why we focus on finding, supporting and sharing evidence-based and measurable ways to improve cancer care.
According to feedback that UCL Saint-Luc collected from patients via its “Je Me GèRe” (JMGR) app, fatigue may be the biggest factor indirectly impacting the quality of life of people living with cancer. We talked to Frédéric Maddalena about the app’s impact and the new features that are available since…
All.Can Belgium is committed to efficiency in cancer care. But what exactly does that mean?
The All.Can Cancer Efficiency Metrics Study (2022) provides an answer to this question. Eight key metrics emerge from this comprehensive international study. These metrics can be used to assess and improve efficiency in cancer care.
All.Can Belgium is committed to efficiency in cancer care. But what exactly does that mean?
The All.Can Cancer Efficiency Metrics Study (2022) provides an answer to this question. Eight key metrics emerge from this comprehensive international study. These metrics can be used to assess and improve efficiency in cancer care.
All.Can Belgium uses these eight parameters to set up and evaluate projects. For example, our ‘Get Checked Early’ campaign emphasises the importance of timely diagnosis and therefore ties in with the first parameter (time to diagnosis).
According to feedback that UCL Saint-Luc collected from patients via its “Je Me GèRe” (JMGR) app, fatigue may be the biggest factor indirectly impacting the quality of life of people living with cancer. We talked to Frédéric Maddalena about the app’s impact and the new features that are available since…
Are you curious about what cancer care in Belgium will look like in the future? Then be sure to mark your calendar for November 6, 2024. On this day, All.Can Belgium will host the conference "Cancer Care: The Future is Now," focusing on the oncological (r)evolution in the 21st century…
Sarcomas are tumours of the bone or soft tissues of the body. Because they are so rare, a lot of healthcare providers fail to recognize the red flags. Prof. Dr. Gwen Sys (Ghent University Hospital) summarizes their main features for her fellow physicians.
Sarcoma patient Eva’s treatment process left much to be desired. The tumor was not identified as malignant until late in the diagnostic process, resulting in a lot of lost time. That's why Eva wants to share her story with others. "I hope other people can learn from it."
When you are diagnosed with cancer, you are faced with 1,001 challenges: not only health-related, but also emotional, social, professional, and economic. As an oncology nurse coordinator, Sylvie Lambin answers her patients' questions and concerns from a professional perspective.
As the elections are approaching, we talked to Professor Dr. Ahmad Awada, Chair of our Board. What is his message for policymakers? "It's impossible to address all cancer care needs simultaneously, which means it's extremely important to focus on efficiency."
